Intragastric Balloon Market Size (2024 - 2029)

The intragastric balloon market is projected to experience significant growth, driven by the rising prevalence of obesity and the increasing preference for minimally invasive treatments. The COVID-19 pandemic has further accelerated this trend, as lifestyle changes during the pandemic led to a surge in obesity rates, thereby boosting the demand for intragastric balloons. The market's expansion is supported by the introduction of new products and the growing acceptance of minimally invasive procedures among patients and healthcare professionals. However, potential side effects and complications associated with intragastric balloons could pose challenges to market growth.

Market Size of Intragastric Balloon Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Intragastric Balloon Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 9.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Intragastric Balloon Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Intragastric Balloon Market Analysis

The intragastric balloon market is expected to register a CAGR of 9.1% over the forecast period.

  • The outbreak of the COVID-19 pandemic impacted the intragastric balloon market. People with an underlying condition such as obesity were at greater risk during the COVID-19 pandemic. For instance, as per the data published by the World Health Organization (WHO), in 2020, more than 1.9 billion adults, 18 years and older, were overweight. Among them, over 650.0 million were obese. Similarly, as per the data published by the CDC in March 2021, around 30.2% of the total COVID-19 hospitalizations were attributed to obesity. In addition, during COVID-19, the obesity rate increased exponentially. 
  • For instance, according to the research article published by the European Journal of Nutrition in December 2021, the rate of obesity increased during the pandemic due to a change in lifestyle and a decrease in exercise practice among people, as they avoided gym and yoga classes due to the social distancing protocols. Thus, such an increased rate of obesity surged the demand for intragastric balloons during the pandemic, and thus, the market witnessed positive growth during COVID-19 and is expected to continue the upward trend over the forecast period.
  • The rising adoption of minimally invasive treatment and the increasing prevalence of obesity are the major factors propelling market growth. For instance, according to the report published by the World Health Organization (WHO) in March 2022, more than 1.0 billion people worldwide are obese, of which 650 million adults, 340 million adolescents, and 39 million children. The same source also stated that by 2025, approximately 167 million people will be obese, including adults and children. Intragastric balloons are widely used for the treatment of obesity and offer effective results. 
  • For instance, according to the National Center for Biotechnology Information (NCBI) study published in January 2023, intragastric balloons serve as a minimally invasive tool to combat the obesity pandemic. There are multiple intragastric balloons approved for the United States and European markets. Indications in the United States include a BMI of 30 to 35 kg/m^2 but a BMI of 27 to 35 kg/m^2 in Europe. Thus, increasing cases of obesity across the globe are expected to positively impact market growth.
  • The increasing preference towards minimally invasive treatment and product launches by the key players are also driving market growth. For instance, according to the NCBI research article published in February 2022, in the studied population, about 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment. Such studies depict the higher acceptance of healthcare professionals and patients of minimally invasive procedures over traditional procedures. Furthermore, in September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks. Therefore, increasing adoption of minimally invasive treatments and product launches are anticipated to propel the market growth over the forecast period.
  • However, the side effects or complications associated with intragastric balloons may hamper the market growth over the forecast period.

Intragastric Balloon Industry Segmentation

An intragastric balloon, also known as a stomach balloon, is used for treating patients who are obese or overweight. These medical devices are kept inside the stomach to reduce weight. 

The intragastric balloon market is segmented by type (single, dual, and triple), filling material (gas-filled and saline-filled), end user (hospitals, ambulatory surgery centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD) for the above segments.

By Type
Single
Dual
Triple
By Filling Material
Gas Filled
Saline Filled
By End User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region Or Segment?
Customize Now

Intragastric Balloon Market Size Summary

The intragastric balloon market is poised for significant growth, driven by the increasing prevalence of obesity and the rising adoption of minimally invasive treatments. The market has shown resilience and positive growth even during the COVID-19 pandemic, as the surge in obesity rates due to lifestyle changes during this period heightened the demand for intragastric balloons. These devices are gaining traction as effective tools for obesity management, with multiple products approved in the United States and European markets. The preference for minimally invasive procedures over traditional methods, supported by healthcare professionals' recommendations, is further propelling market expansion. Key players in the industry are actively launching new products, such as swallowable gastric balloons, to cater to the growing demand for non-surgical weight loss solutions.

North America is expected to maintain a substantial share of the global intragastric balloon market, attributed to the high obesity rates and the widespread adoption of weight loss treatments in the region. The United States, in particular, is witnessing a shift towards value-based care and minimally invasive procedures, which is driving market growth. The presence of major market players and strategic partnerships, such as the collaboration between Pristyn Care and Allurion Technologies, are also contributing to the market's expansion. Despite the competitive landscape, with key companies like Obalon Therapeutics and Apollo Endosurgery Inc. leading the charge, the market continues to evolve with new product developments and favorable initiatives aimed at addressing the obesity epidemic.

Explore More

Intragastric Balloon Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Adoption of Minimally Invasive Treatment

      2. 1.2.2 Increasing Prevalence of Obesity

    3. 1.3 Market Restraints

      1. 1.3.1 Side Effects or Complications Associated with Intragastric Balloons

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Type

      1. 2.1.1 Single

      2. 2.1.2 Dual

      3. 2.1.3 Triple

    2. 2.2 By Filling Material

      1. 2.2.1 Gas Filled

      2. 2.2.2 Saline Filled

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Rest of the World

Intragastric Balloon Market Size FAQs

The Global Intragastric Balloon Market is projected to register a CAGR of 9.10% during the forecast period (2024-2029)

Apollo Endosurgery, Inc., Allurion Technologies Inc, Spatz3, ReShape Lifesciences and Obalon Therapeutics are the major companies operating in the Global Intragastric Balloon Market.

Intragastric Balloon Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)